Literature DB >> 15722651

Control of blood pressure and other cardiovascular risk factors at different practice settings: outcomes of care provided to diabetic women compared to men.

Samy I McFarlane1, Jonathan Castro, Jasjeet Kaur, John J Shin, Douglas Kelling, Amal Farag, Nicole Simon, Fadi El-Atat, Alan Sacerdote, Emad Basta, John Flack, George Bakris, James R Sowers.   

Abstract

Cardiovascular disease (CVD) is the major cause of morbidity and mortality in diabetes. To determine the proportion of patients who met the American Diabetes Association guidelines for control of CVD risk factors and to assess the achievement of these guidelines in women compared with men, we conducted a cross-sectional study of 3678 diabetic cohorts followed at seven medical centers, two Veteran Administration hospitals, three urban clinics, and two suburban clinics. Overall, 28% met the target blood pressure of <130/80 mm Hg, 48.8% achieved a goal low-density lipoprotein cholesterol of <100 mg/dL, and 35.8% had hemoglobin A1c of <7%. Gender comparisons of 2788 diabetic patients at urban and suburban centers showed that women had a lower percentage of low-density lipoprotein cholesterol <100 mg/dL (45.8 vs. 51.3, p<0.01) and a lower percentage of screening for retinopathy (54 vs. 60, p<0.01) and nephropathy (37 vs. 49, p<0.01). However, overall there were no gender differences in the percentage of patients who achieved a goal blood pressure <130/80 mm Hg or hemoglobin A1c <7%. Control of blood pressure and other CVD risk factors in diabetic patients was largely suboptimal, especially for diabetic women. These observations underscore the need for better strategies for control of CVD risk in the diabetic population in general, and women in particular.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15722651      PMCID: PMC8109560          DOI: 10.1111/j.1524-6175.2005.03869.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  39 in total

Review 1.  Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.

Authors:  S M Grundy; I J Benjamin; G L Burke; A Chait; R H Eckel; B V Howard; W Mitch; S C Smith; J R Sowers
Journal:  Circulation       Date:  1999-09-07       Impact factor: 29.690

2.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

3.  Aspirin therapy in diabetes.

Authors:  John A Colwell
Journal:  Diabetes Care       Date:  2003-01       Impact factor: 19.112

4.  Some answers, more controversy, from UKPDS. United Kingdom Prospective Diabetes Study.

Authors:  D M Nathan
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

5.  Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers.

Authors:  Samy I McFarlane; Scott J Jacober; Nathaniel Winer; Jasjeet Kaur; Jonathan P Castro; MaryLou A Wui; Agnes Gliwa; Hans Von Gizycki; James R Sowers
Journal:  Diabetes Care       Date:  2002-04       Impact factor: 19.112

6.  Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

Authors:  R C Turner; C A Cull; V Frighi; R R Holman
Journal:  JAMA       Date:  1999-06-02       Impact factor: 56.272

7.  Treatment of isolated systolic hypertension in the elderly: the Syst-Eur trial. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

Authors:  R H Fagard; J A Staessen
Journal:  Clin Exp Hypertens       Date:  1999 Jul-Aug       Impact factor: 1.749

8.  Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study.

Authors: 
Journal:  Lancet       Date:  2001-03-24       Impact factor: 79.321

9.  Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. The Strong Heart Study.

Authors:  B V Howard; L D Cowan; O Go; T K Welty; D C Robbins; E T Lee
Journal:  Diabetes Care       Date:  1998-08       Impact factor: 19.112

Review 10.  Women--a neglected risk group for atherosclerosis and vascular disease.

Authors:  Leif R Erhardt
Journal:  Scand Cardiovasc J       Date:  2003       Impact factor: 1.589

View more
  15 in total

1.  The DREAM trial and the prospect of diabetes prevention.

Authors:  Samy I McFarlane; Tanja Rundek; John Nicasio; Mrunalini Deshmukh; James R Sowers
Journal:  Curr Diab Rep       Date:  2006-06       Impact factor: 4.810

Review 2.  Gender disparity in outcomes of care and management for diabetes and the metabolic syndrome.

Authors:  Pantelis A Sarafidis; Samy I McFarlane; George L Bakris
Journal:  Curr Diab Rep       Date:  2006-06       Impact factor: 4.810

Review 3.  Cardiovascular disease in diabetes and the cardiometabolic syndrome: focus on minority women.

Authors:  John Nicasio; Fadi El-Atat; Samy I McFarlane; Judith H LaRosa
Journal:  Curr Diab Rep       Date:  2005-06       Impact factor: 4.810

Review 4.  Electrical stimulation of the carotid sinus for the treatment of resistant hypertension.

Authors:  J D Filippone; James A Sloand; Karl A Illig; John D Bisognano
Journal:  Curr Hypertens Rep       Date:  2006-10       Impact factor: 5.369

5.  Drug management for hypertension in type 2 diabetes in family practice.

Authors:  Wayne Putnam; Farokh Buhariwalla; Kendrick Lacey; Mary Goodfellow; Rose Anne Goodine; Jennifer Hall; Ian Macdonald; Michael Murray; Preston Smith; Fred Burge; Nandini Natarajan; Beverley Lawson
Journal:  Can Fam Physician       Date:  2009-07       Impact factor: 3.275

Review 6.  Antidiabetic medications and weight gain: implications for the practicing physician.

Authors:  Samy I McFarlane
Journal:  Curr Diab Rep       Date:  2009-06       Impact factor: 4.810

7.  Risk factor, age and sex differences in chronic kidney disease prevalence in a diabetic cohort: the pathways study.

Authors:  Margaret K Yu; Courtney Rees Lyles; Luis A Bent-Shaw; Bessie A Young
Journal:  Am J Nephrol       Date:  2012-09-04       Impact factor: 3.754

8.  Efficacy and safety of fixed combinations of irbesartan/hydrochlorothiazide in hypertensive women: the inclusive trial.

Authors:  Elizabeth O Ofili; Greg Cable; Joel M Neutel; Elijah Saunders
Journal:  J Womens Health (Larchmt)       Date:  2008 Jul-Aug       Impact factor: 2.681

9.  Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus.

Authors:  Nadia Rashid Al Mazroui; Mostafa Mohamed Kamal; Naserdeen Mehana Ghabash; Targ Ahmed Yacout; Prashant Laxman Kole; James C McElnay
Journal:  Br J Clin Pharmacol       Date:  2009-02-11       Impact factor: 4.335

10.  Treatment of diabetic hypertensive patients: results of a national survey.

Authors:  Marvin Moser; Matthew R Weir
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-02       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.